David H. Bollinger

Array ( [id] => 4403979 [patent_doc_number] => 06271030 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Antisense inhibition of C/EBP beta expression' [patent_app_type] => 1 [patent_app_number] => 9/593711 [patent_app_country] => US [patent_app_date] => 2000-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38319 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271030.pdf [firstpage_image] =>[orig_patent_app_number] => 593711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4265911 [patent_doc_number] => 06306655 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Antisense inhibition of C/EBP alpha expression' [patent_app_type] => 1 [patent_app_number] => 9/593589 [patent_app_country] => US [patent_app_date] => 2000-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31353 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306655.pdf [firstpage_image] =>[orig_patent_app_number] => 593589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7964509 [patent_doc_number] => 06680172 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-20 [patent_title] => 'Treatments and markers for cancers of the central nervous system' [patent_app_type] => B1 [patent_app_number] => 09/571479 [patent_app_country] => US [patent_app_date] => 2000-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24404 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680172.pdf [firstpage_image] =>[orig_patent_app_number] => 09571479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1511380 [patent_doc_number] => 06471968 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Multifunctional nanodevice platform' [patent_app_type] => B1 [patent_app_number] => 09/570198 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23211 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/471/06471968.pdf [firstpage_image] =>[orig_patent_app_number] => 09570198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813590 [patent_doc_number] => 20030073140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Metabolic selection methods' [patent_app_type] => new [patent_app_number] => 09/557796 [patent_app_country] => US [patent_app_date] => 2000-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20877 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073140.pdf [firstpage_image] =>[orig_patent_app_number] => 09557796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813525 [patent_doc_number] => 20030073075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Oligonucleotides labeled with stable isotopes and a method for detecting the same' [patent_app_type] => new [patent_app_number] => 09/535786 [patent_app_country] => US [patent_app_date] => 2000-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4801 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073075.pdf [firstpage_image] =>[orig_patent_app_number] => 09535786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1396206 [patent_doc_number] => 06537754 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Association of kinesin with sensitivity to chemotherapeutic drugs' [patent_app_type] => B1 [patent_app_number] => 09/535789 [patent_app_country] => US [patent_app_date] => 2000-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 16 [patent_no_of_words] => 11684 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537754.pdf [firstpage_image] =>[orig_patent_app_number] => 09535789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7617194 [patent_doc_number] => 06946246 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-20 [patent_title] => 'Production of functional proteins: balance of shear stress and gravity' [patent_app_type] => utility [patent_app_number] => 09/532001 [patent_app_country] => US [patent_app_date] => 2000-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 11122 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946246.pdf [firstpage_image] =>[orig_patent_app_number] => 09532001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570109 [patent_doc_number] => 06498033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Lentiviral vectors' [patent_app_type] => B1 [patent_app_number] => 09/524004 [patent_app_country] => US [patent_app_date] => 2000-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 24263 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498033.pdf [firstpage_image] =>[orig_patent_app_number] => 09524004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301850 [patent_doc_number] => 06187587 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Antisense inhibition of e2f transcription factor 1 expression' [patent_app_type] => 1 [patent_app_number] => 9/517584 [patent_app_country] => US [patent_app_date] => 2000-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23923 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187587.pdf [firstpage_image] =>[orig_patent_app_number] => 517584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234373 [patent_doc_number] => 06165791 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Antisense inhibition of E2F transcription factor 3 expression' [patent_app_type] => 1 [patent_app_number] => 9/513729 [patent_app_country] => US [patent_app_date] => 2000-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29314 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165791.pdf [firstpage_image] =>[orig_patent_app_number] => 513729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535863 [patent_doc_number] => 06337202 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Genes encoding several poly (ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith' [patent_app_type] => B1 [patent_app_number] => 09/511477 [patent_app_country] => US [patent_app_date] => 2000-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 35693 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337202.pdf [firstpage_image] =>[orig_patent_app_number] => 09511477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640370 [patent_doc_number] => 06395543 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Genes encoding several poly(ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith' [patent_app_type] => B1 [patent_app_number] => 09/511507 [patent_app_country] => US [patent_app_date] => 2000-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 24060 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395543.pdf [firstpage_image] =>[orig_patent_app_number] => 09511507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577736 [patent_doc_number] => 06448059 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Methods and composition for inhibition of tRNA activities' [patent_app_type] => B1 [patent_app_number] => 09/506768 [patent_app_country] => US [patent_app_date] => 2000-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8374 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448059.pdf [firstpage_image] =>[orig_patent_app_number] => 09506768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625463 [patent_doc_number] => 06723706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'Modified antisense nucleotides complementary to a section of the human Ha-ras gene' [patent_app_type] => B2 [patent_app_number] => 09/423198 [patent_app_country] => US [patent_app_date] => 2000-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6040 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723706.pdf [firstpage_image] =>[orig_patent_app_number] => 09423198 [rel_patent_id] =>[rel_patent_doc_number] =>)